Format
Items per page
Sort by

Send to:

Choose Destination

Results: 18

Cited In for PubMed (Select 10710227)

1.

Genetic influence of dopamine receptor, dopamine transporter, and nicotine metabolism on smoking cessation and nicotine dependence in a Japanese population.

Ohmoto M, Takahashi T, Kubota Y, Kobayashi S, Mitsumoto Y.

BMC Genet. 2014 Dec 20;15:151. doi: 10.1186/s12863-014-0151-2.

2.

Gene variants associated with antisocial behaviour: a latent variable approach.

Bentley MJ, Lin H, Fernandez TV, Lee M, Yrigollen CM, Pakstis AJ, Katsovich L, Olds DL, Grigorenko EL, Leckman JF.

J Child Psychol Psychiatry. 2013 Oct;54(10):1074-85. doi: 10.1111/jcpp.12109. Epub 2013 Jul 3.

3.

TTC12-ANKK1-DRD2 and CHRNA5-CHRNA3-CHRNB4 influence different pathways leading to smoking behavior from adolescence to mid-adulthood.

Ducci F, Kaakinen M, Pouta A, Hartikainen AL, Veijola J, Isohanni M, Charoen P, Coin L, Hoggart C, Ekelund J, Peltonen L, Freimer N, Elliott P, Schumann G, Järvelin MR.

Biol Psychiatry. 2011 Apr 1;69(7):650-60. doi: 10.1016/j.biopsych.2010.09.055. Epub 2010 Dec 17.

4.

The D2 dopamine receptor gene and nicotine dependence among bladder cancer patients and controls.

Clague J, Cinciripini P, Blalock J, Wu X, Hudmon KS.

Behav Genet. 2010 Jan;40(1):49-58. doi: 10.1007/s10519-009-9301-0. Epub 2009 Oct 15.

5.

Influences of polymorphic variants of DRD2 and SLC6A3 genes, and their combinations on smoking in Polish population.

Sieminska A, Buczkowski K, Jassem E, Niedoszytko M, Tkacz E.

BMC Med Genet. 2009 Sep 17;10:92. doi: 10.1186/1471-2350-10-92.

6.

Genetics of tobacco use.

Maserejian NN, Zavras AI.

Tob Induc Dis. 2004 Jun 15;2(2):81-102. doi: 10.1186/1617-9625-2-2-81.

7.

Association of the DRD2 gene Taq1A polymorphism and smoking behavior: a meta-analysis and new data.

Munafò MR, Timpson NJ, David SP, Ebrahim S, Lawlor DA.

Nicotine Tob Res. 2009 Jan;11(1):64-76. doi: 10.1093/ntr/ntn012. Epub 2009 Jan 27. Review.

8.

Variants in nicotinic acetylcholine receptors alpha5 and alpha3 increase risks to nicotine dependence.

Chen X, Chen J, Williamson VS, An SS, Hettema JM, Aggen SH, Neale MC, Kendler KS.

Am J Med Genet B Neuropsychiatr Genet. 2009 Oct 5;150B(7):926-33. doi: 10.1002/ajmg.b.30919.

9.

DAT genotype modulates brain and behavioral responses elicited by cigarette cues.

Franklin TR, Lohoff FW, Wang Z, Sciortino N, Harper D, Li Y, Jens W, Cruz J, Kampman K, Ehrman R, Berrettini W, Detre JA, O'Brien CP, Childress AR.

Neuropsychopharmacology. 2009 Feb;34(3):717-28. doi: 10.1038/npp.2008.124. Epub 2008 Aug 13.

10.

Gene and gene by sex associations with initial sensitivity to nicotine in nonsmokers.

Perkins KA, Lerman C, Coddington S, Jetton C, Karelitz JL, Wilson A, Jennings JR, Ferrell R, Bergen AW, Benowitz NL.

Behav Pharmacol. 2008 Sep;19(5-6):630-40. doi: 10.1097/FBP.0b013e32830c3621.

11.

Neuroimaging, genetics and the treatment of nicotine addiction.

Ray R, Loughead J, Wang Z, Detre J, Yang E, Gur R, Lerman C.

Behav Brain Res. 2008 Nov 21;193(2):159-69. doi: 10.1016/j.bbr.2008.05.021. Epub 2008 Jun 5. Review.

12.

Genetics and smoking cessation improving outcomes in smokers at risk.

Lerman CE, Schnoll RA, Munafò MR.

Am J Prev Med. 2007 Dec;33(6 Suppl):S398-405. Review.

13.

Pharmacogenetic clinical trial of sustained-release bupropion for smoking cessation.

David SP, Brown RA, Papandonatos GD, Kahler CW, Lloyd-Richardson EE, Munafò MR, Shields PG, Lerman C, Strong D, McCaffery J, Niaura R.

Nicotine Tob Res. 2007 Aug;9(8):821-33. Erratum in: Nicotine Tob Res. 2007 Nov;9(11):1243.

14.

The genetics of nicotine dependence: relationship to pancreatic cancer.

MacLeod SL, Chowdhury P.

World J Gastroenterol. 2006 Dec 14;12(46):7433-9. Review.

15.

Gene variants of brain dopamine pathways and smoking-induced dopamine release in the ventral caudate/nucleus accumbens.

Brody AL, Mandelkern MA, Olmstead RE, Scheibal D, Hahn E, Shiraga S, Zamora-Paja E, Farahi J, Saxena S, London ED, McCracken JT.

Arch Gen Psychiatry. 2006 Jul;63(7):808-16.

16.

Symbiotic relationship of pharmacogenetics and drugs of abuse.

Rutter JL.

AAPS J. 2006 Mar 24;8(1):E174-84. Review.

17.

Nicotine addiction through a neurogenomic prism: ethics, public health, and smoking.

Caron L, Karkazis K, Raffin TA, Swan G, Koenig BA.

Nicotine Tob Res. 2005 Apr;7(2):181-97. Review.

18.

Environmental and genetic determinants of tobacco use: methodology for a multidisciplinary, longitudinal family-based investigation.

Swan GE, Hudmon KS, Jack LM, Hemberger K, Carmelli D, Khroyan TV, Ring HZ, Hops H, Andrews JA, Tildesley E, McBride D, Benowitz N, Webster C, Wilhelmsen KC, Feiler HS, Koenig B, Caron L, Illes J, Cheng LS.

Cancer Epidemiol Biomarkers Prev. 2003 Oct;12(10):994-1005.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk